Buy & Sell Becton Dickinson and Co (BDX) – Becton Dickinson and Co Price Today
Aura AI Summary
Key Stats
- $40.12BMarket Cap
- HealthSector
- -16.24%3M Drawdown
- $56.58BEnterprise Value
- 2.88%Dividend Yield
- 91 daysTypical Hold Time
Becton Dickinson and Co (BDX) is currently valued at a market capitalization of $40.12B, with an enterprise value of $56.58B. Over the past 52 weeks, Becton Dickinson and Co has traded between a low of $132.35 and a high of $185.39, highlighting its annual price range. Over the past three months, Becton Dickinson and Co has recorded a drawdown of -16.24%, reflecting recent price volatility. Becton Dickinson and Co offers a dividend yield of 2.88%, with the most recent dividend of $1.05 paid on 10 Mar 26. On average, investors hold Becton Dickinson and Co for approximately 91 days, indicating typical investor behavior on the platform.
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Most Recent News
Micron CEO sells $36M in stock amid record rally near $1000 per share.
Micron Technology CEO Sanjay Mehrotra sold nearly $36 million worth of company stock last week, offloading 37,439 shares at an average price of $960.38 each. This sale was part of a pre-arranged trading plan and reduces his direct holdings by about 8...

Mobile forensics market to nearly double to $9.99B by 2031, growing at 11.8% CAGR driven by AI and cloud integration.
The global mobile forensics market is projected to grow from $5.72 billion in 2026 to $9.99 billion by 2031, at an 11.8% CAGR. Growth is fueled by increasing mobile ecosystem complexity, widespread use of encrypted apps, and demand for integrated for...

Space stocks plunge over 20% amid SpaceX IPO valuation cut and short squeeze fallout.
Space stocks are sharply down this week, with Redwire, Momentus, and Rocket Lab falling over 20% due to SpaceX's reduced IPO valuation and a failed short squeeze on Virgin Galactic. SpaceX set its IPO price at $135 per share, valuing the company at $...
